...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates
【24h】

Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates

机译:经典的三碳桥的5-取代的呋喃并[2,3-d]嘧啶和6-取代的吡咯并[2,3-d]嘧啶类似物的合成为抗叶酸剂

获取原文
获取原文并翻译 | 示例

摘要

Bridge homologation of the previously reported classical two-carbon-bridged antifolates, a 5-substituted 2,4-diaminofuro[2,3-d]pyrimidine (1) [which is a 6-regioisomer of LY231514 (Alimta)] and a 6-subsituted 2-amino-4-oxopyrrolo[2,3-d]pyrimidine, afforded the three-carbon-bridged antifolates analogues 4 and 5, with enhanced inhibitory activity against tumor cells in culture (EC50 values in the 10(-8)-10(-7) M range or less). These two analogues were synthesized via a 10-step synthetic sequence starting from methyl 4-bromobenzoate (14), which was elaborated to the a-chloromethyl ketone (8) followed by condensation with 2,6-diaminopyrimidin-4-one (7) to afford the substituted furo[2,3-d]pyrimidine 9 and the pyrrolo[2,3-d]pyrimidine 10. Subsequent coupling of each regioisomer with diethyl-L-glutamate followed by saponification afforded 4 and 5. The biological results indicate that elongation of the C8-C9 bridge of the classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidine and 6-substituted 2-amino-4-oxopyrrolo[2,3-d]pyrimidine are highly conducive to antitumor activity in vitro, despite a lack of increase in inhibitory activity against the target enzymes. This supports our original hypothesis that truncation of the B-ring of a highly potent 6-6 ring system to a 6-5 ring system can be compensated by bridge homologation to restore the overall length of the molecule.
机译:先前报道的经典两碳桥连抗叶酸,5-取代的2,4-二氨基呋喃[2,3-d]嘧啶(1)[它是LY231514(Alimta)的6-区域异构体]和6的桥同源物取代的2-氨基-4-氧代吡咯并[2,3-d]嘧啶,提供了三碳桥联的抗叶酸类似物4和5,对培养中的肿瘤细胞具有增强的抑制活性(EC50值在10(-8)中) -10(-7)M范围或更小)。这两个类似物是通过10步合成序列合成的,从4-溴苯甲酸甲酯(14)开始,将其精制为α-氯甲基酮(8),然后与2,6-二氨基嘧啶-4-酮(7)缩合。得到取代的呋喃并[2,3-d]嘧啶9和吡咯并[2,3-d]嘧啶10。随后将每个区域异构体与L-谷氨酸二乙酯偶联,然后进行皂化,得到4和5。生物学结果表明认为经典的5-取代的2,4-二氨基呋喃[2,3-d]嘧啶和6-取代的2-氨基-4-氧吡咯并[2,3-d]嘧啶的C8-C9桥的延伸高度促进尽管缺乏针对靶酶的抑制活性增加,但仍具有体外抗肿瘤活性。这支持了我们最初的假设,即可以通过桥接同源物补偿强力6-6环系统的B环到6-5环系统的截短,以恢复分子的总长度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号